Latest News
Featured News
Scancell announces FDA clearance of IND application for global Phase 3 trial of iSCIB1+ in advanced melanoma
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
Scancell to present at the Sachs 10th Annual Oncology Innovation Forum
Issue of share options
Scancell announces multiple upcoming presentations at the 21st CIMT Annual Meeting
Annual Meeting of The American Association for Cancer Research (AACR), April 2024 in San Diego, California, USA
Annual Report 30th April 2024
Scancell to present at the Annual Immuno-Oncology Summit Europe
Scancell to Present at 2024 AACR Annual Meeting
14th World Antibody-Drug Conjugate Event (ADC), London, March 2024
First Patient dosed with iSCIB1+ in SCOPE trial
Appointment of Sath Nirmalananthan to the Board of Directors
Scancell Announces its Attendance at Upcoming Conferences
Scancell Attends and Sponsors the Annual Melanoma Patient Meeting
No results found.
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.
